Nitroaspirin

N/A

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameNitroaspirin
Drug Alias NameNCX-4016m-NO-ASANO-aspirinm-NO-aspirinNO-ASA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsNitric oxide donors
TargetsCyclooxygenases
Therapy Area/IndicationsDiabetes Mellitus, Type 2Intermittent ClaudicationColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNicox
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNicox Research Institute SrlMario Negri Institute For Pharmacological ResearchStony Brook University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Intermittent ClaudicationColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A